About RYHAX
Rydex Series Funds Health Care Fund H Class is a mutual fund designed to provide capital appreciation by investing primarily in companies operating within the health care industry. Managed as part of the Rydex fund family and advised by Security Investors, LLC, the fund targets a diverse array of health care sectors including pharmaceuticals, biotechnology, medical devices, and health care services. Its portfolio is typically concentrated in large, established firms, with notable holdings that have included Eli Lilly & Co., UnitedHealth Group, Johnson & Johnson, AbbVie, and Abbott Laboratories. The fund generally maintains a high equity allocation, with nearly all assets invested in health care-related stocks and a modest exposure to foreign equities. It features an annual distribution frequency and a net expense ratio of 1.65%. The Rydex Series Funds Health Care Fund H Class serves as a specialized tool for investors seeking exposure to the evolving and pivotal health care sector, which plays a crucial role in global economic and social systems by supporting innovation, patient care, and medical advancement.
Fund Family Rydex Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol RYHAX
Share Class Class H
Index S&P 500 TR
RYHAX had a total return of 23.21% in the past year, including dividends. Since the fund's
inception, the average annual return has been 7.27%.
